Technical Analysis for AOXG - Aoxing Pharmaceutical Company Inc.

Grade Last Price % Change Price Change
grade F 0.0092 13.58% 0.0011
AOXG closed up 13.58 percent on Friday, January 24, 2020, on 3 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical AOXG trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Fell Below 20 DMA Bearish 13.58%
MACD Bearish Centerline Cross Bearish 13.58%
1,2,3 Pullback Bullish Bullish Swing Setup 13.58%
Bollinger Band Squeeze Range Contraction 13.58%
Narrow Range Bar Range Contraction 13.58%
Wide Bands Range Expansion 13.58%
Older signals for AOXG ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiqi Qiangshen Granule, an OTC herbal extraction for tonifying qi and empowering body, and promoting blood circulation to remove meridian obstruction, as well as Tilidine hydrochloride, an orally-absorbed synthetic narcotic analgesic tablet used in 50mg or 100mg dosage for relief of acute, moderate to severe pain, and chronic cancer-related pain. Its products under development comprise Oxycodone and Acetaminophen tablets and capsules, which has completed clinical trials for the treatment of acute and chronic pain; Buprenorphine/Naloxone, a sublingual combo tablet that has completed Phase II clinical trials for the treatment of opioid dependence; and Tilidine/Naloxone, a compound capsule which is in Phase II clinical trial to treat acute and chronic pain. The company was formerly known as China Aoxing Pharmaceutical Company, Inc. and changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. Aoxing Pharmaceutical Company, Inc. was founded in 1655 and is headquartered in Shijiazhuang, China.
RTT Drugs Pharmaceutical Pain Medication Alcohols Morphinans Opioids Opioid Acute And Chronic Pain Drug Rehabilitation Buprenorphine Naloxone Buprenorphine/Naloxone Opioid Antagonists

Is AOXG a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 0.0549
52 Week Low 0.0001
Average Volume 15,360
200-Day Moving Average 0.0181
50-Day Moving Average 0.0123
20-Day Moving Average 0.0100
10-Day Moving Average 0.0111
Average True Range 0.0043
ADX 43.25
+DI 21.8644
-DI 7.7966
Chandelier Exit (Long, 3 ATRs ) 0.0009
Chandelier Exit (Short, 3 ATRs ) 0.0192
Upper Bollinger Band 0.0151
Lower Bollinger Band 0.0049
Percent B (%b) 0.42
BandWidth 102.0000
MACD Line -0.0002
MACD Signal Line -0.0004
MACD Histogram 0.0002
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0092
Resistance 3 (R3) 0.0092 0.0092 0.0092
Resistance 2 (R2) 0.0092 0.0092 0.0092 0.0092
Resistance 1 (R1) 0.0092 0.0092 0.0092 0.0092 0.0092
Pivot Point 0.0092 0.0092 0.0092 0.0092 0.0092
Support 1 (S1) 0.0092 0.0092 0.0092 0.0092 0.0092
Support 2 (S2) 0.0092 0.0092 0.0092 0.0092
Support 3 (S3) 0.0092 0.0092 0.0092
Support 4 (S4) 0.0092